DRUG: FDA DELAYS GRANTING APPROVAL OF AMGEN OSTEOPOROSIS DRUG, DENOSUMAB.
Giant Amgen Has A Lot Riding on The Next Several Months
Monday, October 26, 2009
Headquarters: Thousand Oaks-based Amgen needs drug to be a winner.
Thousand Oaks-based Amgen will have to wait a bit longer to find out whether it can commercialize what some are saying is the biotech giant’s next blockbuster drug, denosumab, also known as Prolia...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 26 biweekly issues
- Subscriber-only digital content for prime stories
- Book of Lists — the most comprehensive business resource in the Valley region